Core Laboratories NV (CLB)
Core Laboratories Inc. specializes in reservoir description and production enhancement services for the oil and gas industry globally, with operations in two segments: Reservoir Description and Production Enhancement. The company offers a range of services, including laboratory analyses, field services, and products for oil and gas reservoirs, supporting enhanced recovery and various energy projects, marketed through sales representatives, seminars, trade shows, and advertising.
Company Info
US21867A1051
N22717107
Sep 20, 1995
Highlights
$526.50M
$0.59
18.32
1.67
$517.80M
$87.57M
$66.80M
$10.14 - $25.07
$15.80
44.35%
12.91
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Core Laboratories NV (CLB) returned -36.19% year-to-date (YTD) and -39.01% over the past 12 months. Over the past 10 years, CLB returned -19.95% annually, underperforming the S&P 500 benchmark at 10.85%.
CLB
-36.19%
-5.81%
-45.88%
-39.01%
-26.16%
-11.24%
-19.95%
^GSPC (Benchmark)
0.51%
6.15%
-2.00%
12.92%
12.68%
14.19%
10.85%
Monthly Returns
The table below presents the monthly returns of CLB, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.96% | -13.74% | 2.46% | -24.15% | -2.91% | -36.19% | |||||||
| 2024 | -10.70% | -5.01% | 14.09% | -7.49% | 18.68% | 8.27% | 20.70% | -20.09% | -5.27% | 2.00% | 7.73% | -14.94% | -1.76% |
| 2023 | 26.30% | -6.72% | -7.62% | 2.09% | -2.80% | 6.31% | 11.78% | -7.47% | -0.12% | -10.79% | -17.28% | -0.28% | -12.72% |
| 2022 | 19.54% | 3.38% | 14.77% | -17.80% | 8.43% | -29.70% | -4.39% | -14.68% | -16.53% | 44.36% | 11.46% | -6.50% | -8.97% |
| 2021 | 24.44% | 7.76% | -18.99% | -2.09% | 48.33% | -6.82% | -14.35% | -17.36% | 0.69% | -6.27% | -11.96% | -2.53% | -15.73% |
| 2020 | -6.14% | -23.60% | -61.48% | 89.65% | 3.17% | 0.49% | 5.02% | -1.88% | -27.09% | -5.24% | 52.04% | 20.66% | -29.05% |
| 2019 | 14.02% | -3.93% | 6.36% | -7.34% | -24.85% | 9.74% | -3.03% | -21.09% | 17.76% | -4.33% | -0.54% | -14.00% | -34.35% |
| 2018 | 4.81% | -9.92% | 5.11% | 13.67% | 1.41% | 1.63% | -10.74% | 2.17% | 1.12% | -26.03% | -2.50% | -28.22% | -44.49% |
| 2017 | -2.23% | -2.06% | 0.96% | -3.60% | -7.74% | -0.95% | -0.20% | -12.28% | 11.93% | 1.83% | 0.85% | 8.73% | -6.83% |
| 2016 | -8.97% | 6.65% | 7.12% | 18.90% | -8.91% | 2.18% | -5.29% | -4.31% | 0.49% | -13.25% | 15.25% | 7.41% | 12.57% |
| 2015 | -22.17% | 18.51% | -4.94% | 26.24% | -10.51% | -2.93% | -3.40% | 5.52% | -13.73% | 17.13% | 1.56% | -7.96% | -7.42% |
| 2014 | -6.05% | 5.10% | 5.53% | -5.20% | -14.83% | 4.51% | -12.08% | 7.89% | -7.37% | -4.30% | -7.67% | -6.59% | -36.24% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of CLB is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Core Laboratories NV (CLB) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Core Laboratories NV provided a 0.36% dividend yield over the last twelve months, with an annual payout of $0.04 per share. The company has been increasing its dividends for 3 consecutive years.
| Period | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $0.04 | $0.04 | $0.04 | $0.04 | $0.04 | $0.28 | $2.20 | $2.20 | $2.20 | $2.20 | $2.67 | $2.00 |
Dividend yield | 0.36% | 0.23% | 0.23% | 0.20% | 0.18% | 1.06% | 5.84% | 3.69% | 2.01% | 1.83% | 2.45% | 1.66% |
Monthly Dividends
The table displays the monthly dividend distributions for Core Laboratories NV. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.02 | |||||||
| 2024 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.04 |
| 2023 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.04 |
| 2022 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.04 |
| 2021 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.04 |
| 2020 | $0.25 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.01 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.28 |
| 2019 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2018 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2017 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2016 | $0.55 | $0.00 | $0.00 | $0.00 | $0.55 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.20 |
| 2015 | $1.02 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $0.55 | $0.00 | $0.00 | $2.67 |
| 2014 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
Dividend Yield & Payout
Dividend Yield
Core Laboratories NV has a dividend yield of 0.36%, which signifies it pays a smaller percentage of its stock price in dividends to its shareholders compared to other companies in the market.
Payout Ratio
Core Laboratories NV has a payout ratio of 4.82%, which is below the market average. This means Core Laboratories NV returns a smaller proportion of its earnings to shareholders as dividends, suggesting it retains a higher portion for reinvestment, growth, or debt payment.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Core Laboratories NV. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Core Laboratories NV was 95.76%, occurring on Mar 17, 2020. The portfolio has not yet recovered.
The current Core Laboratories NV drawdown is 94.09%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.76% | Apr 22, 2014 | 1487 | Mar 17, 2020 | — | — | — |
| -74.19% | Jun 27, 2000 | 573 | Oct 9, 2002 | 706 | Jul 29, 2005 | 1279 |
| -65.38% | Nov 7, 2007 | 277 | Dec 11, 2008 | 341 | Apr 22, 2010 | 618 |
| -59.07% | May 13, 1998 | 77 | Aug 31, 1998 | 401 | Apr 3, 2000 | 478 |
| -35.01% | Nov 12, 1997 | 31 | Dec 26, 1997 | 58 | Mar 23, 1998 | 89 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Core Laboratories NV over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of Core Laboratories NV, comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -6.7%.
Valuation
The Valuation section provides an overview of how Core Laboratories NV is priced in the market compared to other companies in the Oil & Gas Equipment & Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for CLB, comparing it with other companies in the Oil & Gas Equipment & Services industry. Currently, CLB has a P/E ratio of 18.3. This P/E ratio is significantly higher than those of industry peers. This could indicate that the stock is overvalued or that investors expect strong future growth.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for CLB compared to other companies in the Oil & Gas Equipment & Services industry. CLB currently has a PEG ratio of 1.7. This PEG ratio is close to the industry average, suggesting the stock’s valuation is balanced against its growth outlook.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for CLB relative to other companies in the Oil & Gas Equipment & Services industry. Currently, CLB has a P/S ratio of 1.0. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for CLB in comparison with other companies in the Oil & Gas Equipment & Services industry. Currently, CLB has a P/B value of 2.0. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |